Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析

◆英語タイトル:Shanghai RAAS Blood Products Co Ltd (002252) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C12935
◆発行会社(調査会社):GlobalData
◆発行日:2019年1月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Shanghai RAAS Blood Products Co Ltd (002252) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shanghai RAAS Blood Products Co Ltd (Shanghai RAAS) is a biotechnology company that researches, develops, manufactures and distributes blood products (plasma derived medicinal products). The company’s products include human serum albumin, intravenous human immunoglobulin, other blood products, Chinese medicine products and other products. Its products focus on hematology, immunology and intensive care medicine areas. Shanghai RAAS also exports blood products to foreign countries. The company has plasma collection stations across China. Its subsidiaries include Tonrol Bio-Pharmaceutical Co., Ltd., that is involved in product development, production and marketing; and Zhengzhou RAAS Blood Products Company. Shanghai RAAS is headquartered in Fengxian District, Shanghai, China.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Shanghai RAAS Blood Products Co Ltd – Key Facts 5
Shanghai RAAS Blood Products Co Ltd – Key Employees 6
Shanghai RAAS Blood Products Co Ltd – Major Products and Services 7
Shanghai RAAS Blood Products Co Ltd – History 8
Shanghai RAAS Blood Products Co Ltd – Company Statement 9
Shanghai RAAS Blood Products Co Ltd – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Shanghai RAAS Blood Products Co Ltd – Business Description 12
R&D Overview 12
Shanghai RAAS Blood Products Co Ltd – SWOT Analysis 13
SWOT Analysis – Overview 13
Shanghai RAAS Blood Products Co Ltd – Strengths 13
Shanghai RAAS Blood Products Co Ltd – Weaknesses 14
Shanghai RAAS Blood Products Co Ltd – Opportunities 15
Shanghai RAAS Blood Products Co Ltd – Threats 16
Shanghai RAAS Blood Products Co Ltd – Key Competitors 17
Section 3 – Company Financial Ratios 18
Financial Ratios – Capital Market Ratios 18
Financial Ratios – Annual Ratios 19
Performance Chart 22
Financial Performance 22
Financial Ratios – Interim Ratios 23
Financial Ratios – Ratio Charts 24
Section 4 – Company’s Lifesciences Financial Deals and Alliances 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26
Shanghai RAAS Blood Products Co Ltd, Recent Deals Summary 27
Section 5 – Appendix 28
Methodology 28
Ratio Definitions 28
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Shanghai RAAS Blood Products Co Ltd, Key Facts 5
Shanghai RAAS Blood Products Co Ltd, Key Employees 6
Shanghai RAAS Blood Products Co Ltd, Major Products and Services 7
Shanghai RAAS Blood Products Co Ltd, History 8
Shanghai RAAS Blood Products Co Ltd, Subsidiaries 10
Shanghai RAAS Blood Products Co Ltd, Key Competitors 17
Shanghai RAAS Blood Products Co Ltd, Ratios based on current share price 18
Shanghai RAAS Blood Products Co Ltd, Annual Ratios 19
Shanghai RAAS Blood Products Co Ltd, Annual Ratios (Cont...1) 20
Shanghai RAAS Blood Products Co Ltd, Annual Ratios (Cont...2) 21
Shanghai RAAS Blood Products Co Ltd, Interim Ratios 23
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 26
Shanghai RAAS Blood Products Co Ltd, Recent Deals Summary 27
Currency Codes 28
Capital Market Ratios 28
Equity Ratios 29
Profitability Ratios 29
Cost Ratios 30
Liquidity Ratios 30
Leverage Ratios 31
Efficiency Ratios 31

List of Figures
Shanghai RAAS Blood Products Co Ltd, Performance Chart (2013 - 2017) 22
Shanghai RAAS Blood Products Co Ltd, Ratio Charts 24
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 25
Shanghai RAAS Blood Products Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019 26

★海外企業調査レポート[Shanghai RAAS Blood Products Co Ltd (002252):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • University of California Irvine-製薬・医療分野:企業M&A・提携分析
    Summary University of California Irvine (UCI), a subsidiary of University of California is an educational university that provides undergraduate and graduate degree courses and research services. The university provides educational courses in various fields such as business, education, engineering, …
  • Medrobotics Corp:企業の製品パイプライン分析2018
    Summary Medrobotics Corp (Medrobotics), formerly Cardioborobotics Inc, is a medical device company that manufactures and markets flexible robot platforms. The company provides Flex robotic system, a robot-assisted surgical platform that offers physicians with single-site access while operating in ha …
  • Morgan Stanley Smith Barney LLC:企業の戦略的SWOT分析
    Morgan Stanley Smith Barney LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Staples, Inc.:企業の戦略・SWOT・財務分析
    Staples, Inc. - Strategy, SWOT and Corporate Finance Report Summary Staples, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cochin Shipyard Ltd (COCHINSHIP):企業の財務・戦略的SWOT分析
    Cochin Shipyard Ltd (COCHINSHIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Deutsche Borse AG:企業の戦略・SWOT・財務情報
    Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Suburban Propane Partners, L.P.:企業の戦略・SWOT・財務情報
    Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Suburban Propane Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Smurfit Kappa Group plc:企業の戦略・SWOT・財務情報
    Smurfit Kappa Group plc - Strategy, SWOT and Corporate Finance Report Summary Smurfit Kappa Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • MAPFRE RE, Compania de Reaseguros S.A.:企業の戦略・SWOT・財務情報
    MAPFRE RE, Compania de Reaseguros S.A. - Strategy, SWOT and Corporate Finance Report Summary MAPFRE RE, Compania de Reaseguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Bird Rock Bio Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Bird Rock Bio Inc (Bird Rock Bio), formerly RuiYi Inc is a clinical stage biopharmaceutical company that develops immuno-inflammatory regulators and therapeutic antiobodies. The company’s pipeline products include RYI-018, Gerilimzumab and Namacizumab. Its RYI-018 is a peripheral antagonist …
  • NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    NuVista Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian …
  • RPP Infra Projects Ltd (RPPINFRA):企業の財務・戦略的SWOT分析
    RPP Infra Projects Ltd (RPPINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • Tommy Hilfiger Group:企業の戦略・SWOT・財務情報
    Tommy Hilfiger Group - Strategy, SWOT and Corporate Finance Report Summary Tommy Hilfiger Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Chemical Company of Malaysia Bhd (CCM):企業の財務・戦略的SWOT分析
    Chemical Company of Malaysia Bhd (CCM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • YKK Corporation:企業の戦略・SWOT・財務情報
    YKK Corporation - Strategy, SWOT and Corporate Finance Report Summary YKK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Carmanah Technologies Corporation:企業の戦略的SWOT分析
    Carmanah Technologies Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • S&C Electric Co:企業の戦略的SWOT分析
    S&C Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Illumina Inc (ILMN):企業の財務・戦略的SWOT分析
    Illumina Inc (ILMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Aruba Networks, Inc.:企業の戦略・SWOT・財務情報
    Aruba Networks, Inc. - Strategy, SWOT and Corporate Finance Report Summary Aruba Networks, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆